FLUXOR

Italy

This medicinal product is used to treat the symptoms of chronic venous insufficiency of the legs (such as heaviness, swelling, pain, or cramps), capillary fragility (which can cause spots and bruises on the skin), and the symptoms of acute hemorrhoidal crisis (such as pain, swelling, and bleeding in the anal area).

Brand name FLUXOR
Dosage form tablets, film-coated
Active substance / Dosage
Prescription type Non-prescription – not available over the counter
ATC code
Registration number 049772
Manufacturer EPIFARMA S.R.L

Frequently asked questions

How should FLUXOR be taken?

For chronic venous insufficiency, the dose is 2 tablets per day during main meals. In the case of acute hemorrhoidal crisis, the dose is 3 tablets twice daily for the first 4 days, followed by 2 tablets twice daily for the subsequent 3 days. The tablets should be taken during meals.

When should you not take the drug?

You must not take this medicinal product if you are allergic to the active substances or to any of the other components. Use is not recommended in children and adolescents. In case of pregnancy or breastfeeding, it is necessary to consult a doctor as the drug is not recommended due to a lack of clinical data.

What are the possible side effects of FLUXOR?

Common effects include nausea, vomiting, diarrhea, and indigestion. Less common effects include inflammation of the colon. Rare effects include headache, dizziness, malaise, skin rashes, itching, and urticaria. Abdominal pain, swelling of the face or lips, and decreased platelet count have also been reported.

Are there any interactions with other medicines?

No interactions with other medicines are known at this time, but it is always advisable to inform your doctor or pharmacist if you are taking other medications.

What should you do if you forget a dose or if you take too much drug?

In case of omission, do not take a double dose to make up for the missed one. If, however, you take a dose higher than the recommended dose, it is necessary to contact a doctor or pharmacist.

When is it necessary to consult a doctor during treatment?

It is necessary to consult a doctor if symptoms do not improve or if they worsen after 7 days of treatment. In case of venous problems, consult a doctor if you notice skin inflammation, ulcers, or sudden swelling of one or both legs. In case of hemorrhoids, consult a doctor if you notice an increase in rectal bleeding or blood in the stool.

Instructions for use

Package leaflet: Information for the patient

FLUXOR 500 mg film-coated tablets

Micronized flavonoids, as diosmin and other flavonoids expressed as hesperidin
Please read all of this leaflet carefully before taking this medicine because it contains important information for you.
Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist has instructed you.

  • Keep this leaflet. You may need to read it again.
  • If you need more information or advice, consult your pharmacist.
  • If you experience any side effect, including those not listed in this leaflet, contact your doctor or pharmacist. See section 4.
  • Contact your doctor if you do not notice any improvement or if your symptoms worsen after 7 days.

Contents of this leaflet:

  1. What FLUXOR is and what it is used for
  2. What you need to know before taking FLUXOR
  3. How to take FLUXOR
  4. Possible side effects
  5. How to store FLUXOR
  6. Contents of the pack and other information

1. What FLUXOR is and what it is used for

FLUXOR is a vasoprotective agent: it increases venous tone and the resistance of small blood vessels.
FLUXOR is indicated in adults for the treatment of:

  • symptoms related to chronic venous insufficiency of the lower limbs: heaviness, swelling, pain or cramps in the legs;
  • capillary fragility (easy rupture of capillaries, which become visible on the skin and may cause spots and bruising);
  • functional symptoms associated with acute haemorrhoidal crisis, such as pain, bleeding and swelling in the anal region.
    Consult your doctor if you do not feel better or if you feel worse after one week of treatment.

2. What you need to know before taking FLUXOR

Do not take FLUXOR
If you are allergic to the active substances or to any of the other ingredients of this medicine (listed in
section 6).

Warnings and precautions
Talk to your doctor or pharmacist before taking FLUXOR.

Chronic venous disease
If your condition worsens during treatment, with symptoms such as skin or vein inflammation, hardening of the subcutaneous tissue, severe pain, skin ulcers, or atypical symptoms such as sudden swelling of one or both legs, speak to your doctor immediately.
FLUXOR does not help reduce swelling of the lower limbs if this is caused by heart, kidney, or liver diseases.
1 / 4
In case of venous insufficiency, treatment should be combined with a healthy lifestyle to achieve the best results. Avoid sun exposure, heat, prolonged standing, and being overweight.
Walking and wearing special compression stockings improve circulation.

Acute haemorrhoidal disease
If you are experiencing an acute attack of haemorrhoids, you may take FLUXOR only for a limited period of 7 days. If symptoms of acute haemorrhoidal attack do not disappear within 7 days, speak to your doctor.
If your condition worsens during treatment—for example, if you notice increased rectal bleeding, blood in the stool, or have doubts about haemorrhoidal bleeding—consult your doctor immediately.
Treatment with FLUXOR does not replace specific treatment for other anal disorders.
If you have any questions, ask your doctor or pharmacist.

Children and adolescents
The use of FLUXOR is not recommended in children and adolescents.

Other medicines and FLUXOR
Inform your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
No interactions with other medicines are currently known.

Pregnancy and breastfeeding
If you are pregnant, think you might be pregnant, are planning a pregnancy, or are breastfeeding, consult your doctor or pharmacist before taking this medicine.
This medicine is not recommended during pregnancy and breastfeeding due to lack of clinical data.

Driving and using machines
This medicine does not affect or affects negligibly the ability to drive or operate machinery.

FLUXOR contains sodium
This medicine contains less than 1 mmol (23 mg) of sodium per dose, i.e. essentially "sodium-free".

3. How to take FLUXOR

Take this medicine exactly as stated in this leaflet or as instructed by your doctor or pharmacist. If you have any doubts, consult your doctor or pharmacist.
Chronic venous insufficiency
The recommended dose for adults is 2 tablets daily, taken with main meals (lunch and dinner), including in cases of haemorrhoids.
Do not exceed the maximum daily dose.
Treatment may last up to 8 weeks. Contact your doctor if you do not feel better or if you feel worse; your doctor will assess whether treatment should continue.
Acute haemorrhoidal attack
During the first 4 days of treatment, the recommended dose for adults is 3 tablets twice daily (6 tablets per day). During the following 3 days, the dose is 2 tablets twice daily (4 tablets per day).
Do not exceed the maximum daily dose.
Take these tablets with meals.
If you are taking FLUXOR to treat symptoms of acute haemorrhoidal disease, consult your doctor or pharmacist if you do not feel better or if you feel worse after 7 days.
If you take more FLUXOR than you should
If you have taken more FLUXOR than you should, contact your doctor or pharmacist.
Experience with overdose of micronized flavonoids is limited. Possible adverse effects in case of overdose may include diarrhoea, nausea, abdominal pain, pruritus, and skin rash.
If you forget to take FLUXOR
Do not take a double dose to make up for the missed dose.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everyone will experience them.
The side effects that may occur with the frequency described below include:
Common (may affect up to 1 in 10 people)
Nausea, vomiting, diarrhoea, indigestion (dyspepsia).
Uncommon (may affect up to 1 in 100 people)
Inflammation of the colon (colitis).
Rare (may affect up to 1 in 1,000 people)
Headache, dizziness, malaise, skin rash, itching, urticaria.
Not known (frequency cannot be estimated from the available data)
Abdominal pain, abnormally low platelet count (thrombocytopenia), swelling of the face, lips or eyelids (edema) associated with allergic symptoms. In very rare cases, rapidly developing swelling of the face, lips, mouth, tongue or pharynx may occur, which may be accompanied by breathing difficulties (angioedema, Quincke's edema).

Reporting of side effects
If you experience any side effect, including those not listed in this leaflet, talk to your doctor or pharmacist.
You can also report side effects directly via the national reporting system at https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse.
By reporting side effects, you can help provide more information on the safety of this medicine.

5. How to store FLUXOR

Keep this medicine out of the sight and reach of children.
OPA/AL/PVC blister packs: This medicine does not require any special storage conditions.
PVC/AL blister packs: Store below 25°C.
Do not use this medicine after the expiry date stated on the packaging after “Exp”. The expiry date refers to the last day of that month.
Do not dispose of medicines via wastewater or household waste. Ask your pharmacist how to dispose of medicines you no longer use. This will help protect the environment.

6. Package contents and other information

What FLUXOR contains
3 / 4
The active substance consists of micronized flavonoids, including diosmin and other flavonoids expressed as hesperidin. Each film-coated tablet contains 500 mg of micronized flavonoids, of which 450 mg is diosmin and 50 mg other flavonoids expressed as hesperidin.

The other components are:
Tablet core: gelatin, sodium lauryl sulfate, sodium starch glycolate (type A), microcrystalline cellulose, magnesium stearate, talc.
Coating: hypromellose (E464), titanium dioxide (E171), glycerol (E422), magnesium stearate (E470b), yellow iron oxide (E172), red iron oxide (E172), macrogol (E1521).

Description of the appearance of FLUXOR and package contents
FLUXOR is presented in a cardboard box containing blisters made of OPA/AL/PVC or PVC/AL, with 30, 60 or 120 salmon-pink, oblong, film-coated tablets.
Not all pack sizes may be marketed.

Marketing Authorization Holder
Epifarma S.r.l. - Via San Rocco, 6 – 85033 Episcopia (PZ), Italy

Manufacturer
Doppel Farmaceutici S.r.l. – Via Volturno, 48 – 20089 Quinto De’ Stampi - Rozzano (MI), Italy
4 / 4

Similar drugs

The original data is available in the language of the country of manufacture.

Data source: Italian Medicines Agency (AIFA)

Data last verified: September 21, 2026